relationship between the toxic effect of propylthiouracil (PTU) and myeloperoxidase activity of rat bone marrow was examined. The administration of PTU for 1 or 2 weeks caused a decrease in leukocyte count with the concomitant inhibition of the activity of myeloperoxidase in the bone marrow. The decreases in both leukocyte counts and myeloperoxidase activity were restored to control levels at 2 weeks after the discontinuation of the administration. PTU treatment did not affect the affinity of H202 for the enzyme; however, an increase in the Knl value for guaiacol was seen.
Abstract-The
relationship between the toxic effect of propylthiouracil (PTU) and myeloperoxidase activity of rat bone marrow was examined.
The administration of PTU for 1 or 2 weeks caused a decrease in leukocyte count with the concomitant inhibition of the activity of myeloperoxidase in the bone marrow. The decreases in both leukocyte counts and myeloperoxidase activity were restored to control levels at 2 weeks after the discontinuation of the administration. PTU treatment did not affect the affinity of H202 for the enzyme; however, an increase in the Knl value for guaiacol was seen.
PTU, incubated with bone marrow peroxidase in vitro increased the Km value of the enzyme for guaiacol, but had no effect on the Kn, value for H2O2. The results suggest that the mechanism of inhibition of myeloperoxidase activity by PTU given in vivo or incubated with the enzyme in vitro may be the same. The activity of bone marrow glutathione peroxidase was not influenced by PTU treatment.
Myeloperoxidase
(donor: hydrogen per oxide oxidoreductase, EC 1.11.1.7) catalyzes the oxidation of some organic substrates in the presence of hydrogen peroxide (1) . This enzyme appears in the leukocyte during maturation (2). The activity of myeloper oxidase in human leukemia line HL-60 cells has been found to change markedly during in vitro cell differentiation (3). Thus, the activity of myeloperoxidase in the bone marrow appears to be related to granulocyte differentiation.
PTU, one of the thioureylene antithyroid drugs, inhibits the synthesis of thyroid hormones by preventing thyroid peroxidase catalyzed iodination of thyrogloblin (4-7). It is recognized that thioureylene antithyroid drugs such as PTU and methimazole caused bone marrow depression during the treatment of hyperthyroidism (8, 9). However, the mechanism of agranulocytosis and leukopenia induced by PTU is uncertain.
Previously, it was found that the adminis tration of 0.5-1.5 mmol/kg PTU to rats for 1 or 2 weeks caused a dose-dependent de crease in leukocyte counts (10). Thus, the rats treated with toxic doses of PTU serve as a useful model for an adverse reaction of PTU, namely granulocytopenia. In PTU treated rats, the decrease in leukocyte count was accompanied by a reduction in the spleen weight (11 ) and by an increase in the activity of GSH S-transferase of the liver (12). Little is known about the relationship between the effect of PTU on the leukocyte counts and bone marrow function.
In for 60 min. The resulting pellet was resuspended and the centrifugation repeated. The final pellet was suspended in 0.25 M sucrose and used as the enzyme source.
Assay of enzyme activity: Myeloperoxidase activity was measured using guaiacol as the electron donor. The assay system for the enzyme activity consists of 100 mM potassium phosphate buffer (pH 7.0), 33 mM guaiacol, 0.5 mM H202 and the enzyme (2.5 ng protein) in a total volume of 1.0 ml. The reaction was started by adding H202 and was followed at 470 nm using a recording spectrophotometer (Hitachi, model 100-21) at 25°C. A guaiacol unit (GU) was defined as the oxidation of 1 /Lmol e of guaiacol per minute based on the absorption coefficient for tetraguaiacoquinone of 5.57 cm-1 mM-1 (13). In some experiments, 5 mM potassium iodide was used as the electron donor instead of guaiacol. The rate of the oxidation of iodide was followed spectrometrically at 350 nm. A iodide unit (IU) was defined as the oxidation of 1 pmole iodide per minute based on the absorption coefficient for iodide of 26.0 cm-' mM-1 (13). The activity of GSH peroxidase was determined as previously described (14). Protein was measured by the method of Lowry et al. (15) .
The statistical significance of differences between the means were determined using the unpaired t-test. 
Results
As reported previously (10, 11), PTU (1.5 mmol/kg) repeatedly administered to rats for 1 or 2 weeks significantly decreased the leukocyte counts ( Table 1 ). The leukocyte counts in rats treated with PTU for 2 weeks returned to the control value by 2 weeks after the discontinuation of the administration of PTU. In contrast, the erythrocyte counts were unchanged by PTU administration for even 2 weeks (Table 1 ). Table 1 also shows that the PTU treatment for 1 or 2 weeks caused a decrease in myeloperoxidase activity of the bone marrow. The decrease in enzyme activity was restored at 2 weeks after dis continuation of the administration of PTU. Thus, the decrease in both leukocyte number and myeloperoxidase activity by PTU treatment was reversible. The decrease in the myeloperoxidase activity caused by PTU administration for 2 weeks was also observed when potassium iodide was used instead of guaiacol for the assay of the enzyme activity (control, 3.92+0.59; PTU, 2.11 +0.23 lU/mg protein).
No change in myeloperoxidase activity was seen at 3, 6 and 24 hr after adminis tration of a single dose of 1.5 mmol/kg PTU. In addition, leukocyte counts were not influenced by the acute administration (data not shown). The activity of GSH peroxidase was not affected by the administration of PTU for 2 weeks ( Table 1 ) .
As shown in Fig. 1 , PTU treatment de creased the Vm" of myeloperoxidase without affecting the Km of the enzyme for H202.
Thus, the affinity of the enzyme for H202 was not changed by PTU treatment. In contrast, the Km value for guaiacol was increased by repeated-administration of PTU (Fig. 1 ) . Fig. 1 . Double reciprocal plots of bone marrow myeloperoxidase activity from rat treated with (0) or without (ID) PTU. 1.5 mmol/kg PTU was administered daily for 2 weeks , bone marrow cells were removed, and the myeloperoxidase activity was determined 24 hr after the final dose. Azide and cyanide inhibit myeloperoxidase (16) through the interaction with the heme iron of the enzyme (17). Figure 2 shows that these compounds inhibited the bone marrow myeloperoxidase activity in a concentration dependent manner. The concentration response curves for azide and cyanide in the control were the same as in PTU-treated rats. The IC50 values for azide and cyanide were 22 and 23 W, respectively. Figure 3 shows the effect of PTU on myeloperoxidase activity in vitro. PTU markedly inhibited the activity of myelo peroxidase, with an IC50 value of 21 ,tM. PTU, in vitro, caused a decrease in the V,,,,,, of the enzyme without affecting the K,, value for H202. However, an increased K,, value for guaiacol was observed (Fig. 4) . Fig. 3 . Effect of the concentration of PTU on myeloperoxidase activity of rat bone marrow in vitro. PTU was added to the reaction mixture for the assay of myeloperoxidase (See Materials and Methods). The control value was 5.22 GU/mg protein. Discussion PTU, which is used as an antithyroid drug, exhibits toxic effects in mammals, including the induction of leukopenia (8). It is well established that thioureylene antithyroid drugs inhibit thyroid peroxidase (4-7). However, the inhibition of myeloperoxidase in bone marrow by PTU in vivo has not been demonstrated.
The present study revealed that PTU treatment caused the inhibition of myeloperoxidase in rat bone marrow. Leukopenia was also observed when PTU was administered to rats for 1 or 2 weeks. Thus, the decrease in leukocyte count caused by repeated administration of PTU parallels the inhibition of myeloperoxidase activity. A single administration of 1.5 mmol/kg PTU had no effect on the leukocyte counts or the activity of the enzyme. Although the role of myeloperoxidase in the bone marrow is unknown, the enzyme activity changes during cell differentiation (3).
PTU inhibits thyroid functions by inhibiting thyroid peroxidase (4-7).
A decrease in thyroid function causes a lowering of hematopoiesis (18), decreasing not only the number of leukocytes but also the number of erythrocytes.
As shown in Table 1 , PTU treatment decreased only leukocyte number. These findings indicate that the leukopenia induced by the repeated administration of PTU is not likely due to a decrease in thyroid function.
The inhibition of the enzyme activity in bone marrow was selectively observed in myeloperoxidase.
GSH peroxidase also decomposes hydrogen peroxide (19). However, the activity of GSH peroxidase was not influenced by PTU treatment for 2 weeks.
PTU also inhibits the activity of myelo peroxidase of the bone marrow in vitro. In vitro, PTU decreases the myeloperoxidase activity noncompetitively with respect to H202 and increased the Kn, value for guaiacol. The same results were also obtained in vivo. Therefore, inhibition of myeloperoxidase activity by PTU treatment in vivo may be due to the same mechanism observed in vitro. In another experiment, the 105,000xg pellet of the bone marrow was solubilized by cetyltrimethylammonium bromide and chro matographed on Sephacryl S-200 to partially purify the myeloperoxidase.
The specific activities of the chromatographic peaks containing enzyme activity were 32.3 and 14.6 GU/mg protein in the control and PTU treated rats, respectively. Thus, the decreased activity of myeloperoxidase following PTU treatment was also observed in the partially purified preparation of the enzyme. These results indicate that PTU irreversibly in activated myeloperoxidase in the bone marrow.
Azide and cyanide, which were typical peroxidase inhibitors, depressed myeloperoxi dase activity in the control as well as in PTU treated rats. In addition, the degree of inhibition by azide and cyanide in the control was not different from that in PTU-treated animals, suggesting that PTU treatment does not interfere with the heme group of myelo peroxidase in the bone marrow.
The above evidences indicate that leukopenia may be related to the inhibition of bone marrow myeloperoxidase in the rats repeatedly administered with PTU.
